LAST PRICE - AT THE CLOSE
DRUG is DOWN -34% since the begininning of the year
DRUG is DOWN -20% BELOW 20 day SMA
DRUG is DOWN -33% BELOW 200 day SMA
PROFITABLE: NO
EPS: $-0.536582
EARNINGS MOMENTUM: YES
0.14% INCREASE IN QTRLY EARNINGS
P/E RATIO IS: N/A
INCOME TO DEBT RATIO: 0.00
 |
THE STOCK IS 58.1% AWAY FROM ALL-TIME HIGHS OF $123.75 |
 |
DRUG IS DOWN -34% SINCE THE BEGINNING OF THE YEAR |
 |
DRUG IS DOWN -1% OVER THE PAST 12 MONTHS |
 |
DRUG IS DOWN -32% OVER THE PAST 1 MONTH |
 |
6% OF ALL DRUG INVESTORS ARE BETTING AGAINST DRUG |
 |
NUM INVESTORS SHORT DRUG HAS GONE UP N/A% VERSUS LAST MONTH |
| Type | Description | Time |
|---|
 |
DRUG moved up 0 in the previous minute |
 |
DRUG is up 2.14 over the last hour |
 |
DRUG is up 14.4% over the last 5 days |
 |
DRUG is 10.9 above its 8 day SMA |
| $51.41 |   DAY |
$54.37 |
| $52.91 | PREVIOUS DAY |
$58.30 |
| $52.91 | WEEK |
$62.45 |
| $52.91 | MONTH |
$76.80 |
| $0.94 | YEAR |
$123.75 |
DRUG is mentioned N/A less than normal on 
DRUG is mentioned N/A times in an average day on 
